Matches 1 - 50 out of 197 1 2 3 4 >


Match Document Document Title
US20140271866 TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING RIVASTIGMINE  
The present invention provides a transdermal drug delivery system comprising rivastigmine or its pharmaceutically acceptable salt and method of making the same.
US20110293721 PIROXICAM-CONTAINING MATRIX PATCHES AND METHODS FOR THE TOPICAL TREATMENT OF ACUTE AND CHRONIC PAIN AND INFLAMMATION THEREWITH  
This invention relates to matrix patches for the topical (i.e., transdermal) delivery of piroxicam and methods for the treatment of acute and chronic pain and inflammation therewith, particularly...
US20120107394 IMMUNO-COMPATIBLE HYDROGEL SYSTEM  
An immuno-compatible hydrogel system is provided that is resistant to protein binding. The hydrogel system is prepared by contacting a hydrogel solution with a cross-linking agent to form a gel,...
US20110129535 TRANSDERMAL TESTOSTERONE DEVICE AND DELIVERY  
Described are transdermal drug delivery systems for the transdermal administration of testosterone, comprising a polymer matrix and testosterone. Methods of making and using such systems also are...
US20140294953 Abuse-Resistant Formulations  
The disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The...
US20110027172 DRUG DELIVERY SYSTEM FOR PHARMACEUTICALS AND RADIATION  
The present invention provides a drug delivery system for delivery of an agent and a radiopharmaceutical agent. The drug delivery system may specifically target an organ, tissue, cells,...
US20150098997 Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions  
Aspects of the invention include methods of treating ADHD, anxiety or insomnia by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver an amount of...
US20120231075 ABUSE-RESISTANT OPIOID DOSAGE FORM  
We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.
US20110020444 ABUSE-RESISTANT OPIOID DOSAGE FORM  
We provide a pharmaceutical dosage form including an opioid antagonist surrounded by a controlled release matrix and an opioid agonist in a surrounding matrix.
US20100008991 Transdermal estrogen device and delivery  
Described are transdermal drug delivery systems for the transdermal administration of estrogen, comprising a polymer matrix and estrogen. Methods of making and using such systems also are described.
US20130171256 ALCOHOL-RESISTANT EXTENDED RELEASE DOSAGE FORMS COMPRISING VENLAFAXINE  
This disclosure relates to an extended release oral dosage form comprising a matrix containing a viscosity modifier (but no lipid) and coated granules containing venlafaxine or a pharmaceutically...
US20110300212 Pharmaceutical Formulation  
The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a...
US20110104273 GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR IMMEDIATE AND EXTENDED RELEASE OF PHENYLEPHRINE  
Gastric retentive dosage forms for both immediate and extended release of phenylephrine are described which allow once- or twice-daily dosing. Methods of treatment using the dosage forms and...
US20110171309 Compositions and Methods for Composite Nanoparticle Hydrogels  
Provided herein are systems, methods, and compositions for composite nanoparticle hydrogel networks and systems responsive to a first temperature.
US20110111033 HYDROGEL WITH COVALENTLY CROSSLINKED CORE  
A novel hydrogel system is provided. The hydrogel system comprises a biocompatible hydrogel core having dispersed therein a covalently crosslinked polymer matrix. The hydrogel system is useful per...
US20080177213 Hydrogels of hydrophilic polyurethanes (meth)acrylates  
The present invention provides hydrogels formed from polyurethane (meth)acrylates in water using water-soluble redox initiators.
US20110104283 COMPOSITIONS AND METHODS OF NATURAL PRODUCTS IN NANOFORMULATIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS  
A composition and method for treating a bone condition of an animal. The composition includes a nanoformulation of active ingredients. The active ingredients include Lepidium Sativum or other...
US20070110812 Ophthalmic composition for dry eye therapy  
Disclosed in embodiments are gel formulations which are not subject to the settling out phenomena that may be observed with Loteprednol etabonate suspensions.
US20130189333 ORAL PRODUCT  
An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and an...
US20110150994 Modified Release Formulation  
The invention is directed to the use of an extended release tablet formulation for pramipexole.
US20110244045 CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION  
The present invention provides a controlled-release composition which provides a therapeutically effective plasma concentration of N-acetylcysteine over prolonged period of time. The present...
US20140112980 ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS  
An abuse-resistant controlled release pharmaceutical composition comprising a pharmaceutically effective amount of discrete particles of an active capable of abuse, wherein surfaces of said...
US20110206769 ORAL ANTIDEPRESSANT FORMULATION WITH REDUCED EXCIPIENT LOAD  
Provided are methods for reducing the excipient load of pharmaceutical formulations containing 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiin 10,10-dioxide as the active pharmaceutical ingredient,...
US20070254036 Treatment of menopause associated symptoms  
Described are estradiol-containing pharmaceutical compositions and, and methods using the same to alleviate menopause-related symptoms, such as hot flushes, by topically administering estradiol at...
US20140105979 COMPOSITIONS AND METHODS FOR THE TRANSDERMAL DELIVERY OF METHYLPHENIDATE  
Compositions for the transdermal delivery of methylphenidate in a flexible, finite form are described. The compositions comprise a polymer matrix that includes methylphenidate or a...
US20100323015 MODIFIED RELEASE FORMULATION AND METHODS OF USE  
A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl) carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate...
US20110318413 EXTENDED RELEASE FORMULATIONS CONTAINING DARIFENACIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF  
The present invention relates to an extended release formulation comprising darifenacin or pharmaceutically acceptable salts thereof and one or more release controlling hydrophobic materials...
US20110111034 METHOD AND MATERIAL FOR ENHANCED TISSUE-BIOMATERIAL INTEGRATION  
The present invention relates to the covalent binding of a hydrogel to an extracellular matrix (ECM). The integration of the hydrogel with the tissue is superior to that in previous techniques....
US20100143478 TREATMENT OF INFLAMMATION AND THE COMPLEMENT AND KININ CASCADES IN A PATIENT, PARTICULARLY IN CHRONIC ULCEROUS SKIN LESIONS  
The invention provides methods of inhibiting inflammation and/or the complement cascade and/or the kinin cascade in a human or non-human animal patient, particularly in a wound (for example, a...
US20110238036 SUSTAINED RELEASE DELIVERY DEVICES  
An injectable drug delivery device includes a core containing one or more drugs and one or more polymers. The core may be surrounded by one or more polymer outer layers (referred to herein as...
US20120064142 POLYMERIC PHARMACEUTICAL DOSAGE FORM IN SUSTAINED RELEASE  
This invention relates to a polymeric pharmaceutical dosage form for the delivery, in use, of at least one pharmaceutical composition in a rate-modulated and site-specific manner. The dosage form...
US20120201891 TRANSDERMAL DELIVERY PATCH  
A composition suitable for use in a transdermal delivery patch for administration of a biologically active compound, the composition comprising a phosphate compound of tocopherol and a polymer...
US20080207779 Electrically conductive hydrogels  
Electrically conductive adhesive hydrogels formed from a composition which generally includes a monomer, an initiator, an organic solvent, and a cross-linking agent are suitable for use as skin...
US20130273162 Oral Film Containing Opiate Enteric-Release Beads  
A control release and abuse-resistant opiate drug delivery oral wafer or edible oral film dosage to treat pain and substance abuse is provided. The drug delivery oral wafer or edible oral film...
US20120021053 CONTROLLED RELEASE AND TASTE-MASKING ORAL PHARMACEUTICAL COMPOSITION  
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic,...
US20090324722 CARTILAGE FILLING DEVICE  
Compositions and methods for treating a tissue defect.
US20110059176 MATERIAL FOR PREVENTING TISSUE ADHESION AND MATERIAL FOR PREVENTING JOINT CONTRACTURE  
The present invention provides a tissue adhesion prevention material preparable at an affected area at the time of surgical procedure by producing a three-dimensional polymeric structure having a...
US20110200655 Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic  
A medical product is provided that is selected from at least one of, nasal cannulas, oxygen masks, wound dressings, bandages, band aids, catheters, endotrachial tubes, condoms, surgical and other...
US20120003316 TRANSMUCOSAL DELIVERY SYSTEM  
This invention relates to a multi-configured, transmucosal pharmaceutical dosage form and, more particularly, to a pharmaceutical dosage form which has a single monolithic/heterogeneous layer or a...
US20100285133 TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING GRANISETRON  
Disclosed herein is a transdermal system in a matrix form capable of enhancing granisetron carrying efficiency and improving transdermal absorption while inhibiting recrystallization, which...
US20110287078 NOVEL POROUS BIOMATERIALS  
The invention provides porous biomaterials and methods for forming porous biomaterials. The porous biomaterials of the invention comprise a biocompatible polymer scaffold defining an array of...
US20090022780 HYDROGEL  
The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds.
US20140127300 ABUSE RESISTANT DRUG FORMS  
The invention is directed to oral drug dosage forms designed to reduce the abuse potential of an oral dosage form of an opioid analgesic. The oral drug dosage form comprises a first population of...
US20110223230 HYDROGEL FORMULATIONS  
A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the hydrogel and the biologically active...
US20120288566 LIQUID PRECURSOR COMPOSITIONS AND USES THEREOF FOR A PH-DEPENDANT SUSTAINED RELEASE TREATMENT OF ORAL DISORDERS  
The present invention discloses liquid precursor compositions adapted for application on a hard surface in the oral cavity, comprising at least one therapeutic agent suitable for the treatment of...
US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis  
The present invention provides materials that have high glucose and oxygen permeability, strength, water content, and resistance to protein adsorption. The materials include an interpenetrating...
US20120263792 DUAL DRUG DOSAGE FORMS WITH IMPROVED SEPARATION OF DRUGS  
Drug tablets that include a prolonged-release core and an immediate-release layer or shell are prepared with a thin barrier layer of drug-free polymer between the prolonged-release and...
US20050281881 Self-adhesive polymer matrix containing sea algae extract and glycerin  
A self-adhesive polymer matrix which comprises a polymer that forms a gel in water, water, a sea algae extract, and a monohydric or polyhydric alcohol.
US20070259045 Alcohol Resistant Dosage Forms  
Disclosed in certain embodiments is a controlled release dosage form comprising a matrix comprising a pharmaceutically acceptable salt of an opioid analgesic in a controlled release material;...
US20140271865 AMPHETAMINE TRANSDERMAL COMPOSITIONS WITH ACRYLIC BLOCK COPOLYMER  
Described are transdermal drug delivery compositions comprising amphetamine, methods of making them and therapeutic methods using them. The compositions are provided in a flexible, finite form...

Matches 1 - 50 out of 197 1 2 3 4 >